Target Name: KRT17P2
NCBI ID: G339241
Other Name(s): keratin 17 pseudogene 2 | Keratin 17 pseudogene 2

KRT17P2: A Potential Drug Target and Biomarker

Keratin 17 (K17) is a protein that plays a crucial role in the structure and function of hair. It is a large transmembrane protein that contains multiple domains, including an extracellular domain (ECD), a transmembrane domain (TMD), and an intracellular domain (ICD). K17 is expressed in a variety of tissues, including scalp, skin, and hair, and is involved in numerous cellular processes, including cell growth, differentiation, and signaling.

Recent studies have identified K17 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the potential of K17 as a drug target and biomarker, and discuss recent research on its role in these areas.

K17 as a Drug Target

K17 has been identified as a potential drug target due to its involvement in several cellular processes that are associated with various diseases. One of the key reasons for its potential as a drug target is its involvement in cell signaling pathways. K17 has been shown to be involved in several signaling pathways that are involved in cellular processes that are associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

For example, K17 has been shown to be involved in the regulation of cell growth and differentiation. K17 has been shown to play a role in the regulation of cell cycle progression, and has been shown to interact with several transcription factors, including nuclear factor (NF) -kappa-B, which is involved in the regulation of cellular processes that are associated with the development and progression of cancer.

K17 has also been shown to be involved in the regulation of cell survival and apoptosis. K17 has been shown to play a role in the regulation of cell survival and apoptosis, and has been shown to interact with several stress-responsive pathways, including the unfoldasome-associated protein (FAP) signaling pathway.

In addition to its involvement in cellular signaling pathways, K17 has also been shown to be involved in the regulation of skin and hair growth and development. K17 has been shown to play a role in the regulation of skin and hair growth and development, and has been shown to interact with several transcription factors, including Dazl (Dazl gene 1), which is involved in the regulation of skin and hair growth and development.

K17 as a Biomarker

In addition to its potential as a drug target, K17 has also been shown to be a potential biomarker for several diseases. For example, K17 has been shown to be involved in the regulation of skin and hair growth and development, which could make it an attractive biomarker for diseases associated with these processes, such as cancer, neurodegenerative diseases, and autoimmune disorders.

K17 has also been shown to be involved in the regulation of cell survival and apoptosis, which could make it an attractive biomarker for diseases associated with these processes, such as neurodegenerative diseases and cancer. In addition, K17 has been shown to play a role in the regulation of cell cycle progression, which could make it an attractive biomarker for diseases associated with cellular processes that are associated with the development and progression of these diseases.

Recent Studies

Recent studies have further demonstrated the potential of K17 as a drug target and biomarker. For example, researchers have shown that inhibiting the activity of K17 can lead to the growth arrest and apoptosis of cancer cells. This suggests that K17 may be an attractive drug target for cancer treatment.

In addition, researchers have also shown that K17 is involved in the regulation of

Protein Name: Keratin 17 Pseudogene 2

More Common Targets

KRT17P3 | KRT17P5 | KRT17P7 | KRT18 | KRT18P1 | KRT18P12 | KRT18P13 | KRT18P16 | KRT18P17 | KRT18P19 | KRT18P22 | KRT18P23 | KRT18P24 | KRT18P27 | KRT18P28 | KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36